脑机接口医疗服务“官方价”出炉，临床应用驶入快车道

Core Insights - The establishment of pricing mechanisms for brain-computer interface (BCI) services by the National Healthcare Security Administration (NHSA) is expected to accelerate the clinical application and commercialization of BCI technology in China [1][3][7] - The pricing for invasive and non-invasive BCI procedures has been set, with specific fees established in provinces such as Hubei, Zhejiang, and Jiangsu, indicating a structured approach to integrating BCI into healthcare [4][3] - The rapid development of BCI technology is supported by government policies and the establishment of clinical transformation centers across multiple cities, facilitating the transition from laboratory research to practical application [2][7] Pricing Mechanism - NHSA has introduced specific pricing for BCI services, including "invasive BCI implantation fee," "invasive BCI extraction fee," and "non-invasive BCI adaptation fee," which will provide a clear framework for clinical applications [3][4] - Hubei province has set the invasive BCI implantation fee at 6,552 yuan per instance, the extraction fee at 3,139 yuan, and the adaptation fee at 966 yuan, with additional charges for pediatric cases [3][4] - Zhejiang and Jiangsu provinces have also published similar pricing structures, indicating a coordinated effort to standardize BCI service costs across regions [4][3] Clinical Application and Development - The establishment of clinical transformation centers in cities like Beijing, Wuhan, and Shanghai marks a significant step in the practical application of BCI technology, allowing for clinical trials and real-world data collection [7][8] - The first clinical ward dedicated to BCI technology was opened at Beijing Tiantan Hospital, highlighting the transition of BCI from research to clinical practice [7] - The successful completion of China's first prospective clinical trial for invasive BCI technology signifies a major milestone in the country's BCI development, positioning it as a leader in this field after the United States [7][8] Market Potential - McKinsey forecasts that the global market for BCI medical applications could reach $40 billion by 2030 and $145 billion by 2040, with significant growth expected in areas such as central nervous system disease treatment and emotional assessment [8] - The market for central nervous system disease treatment is projected to be $15 billion by 2030 and $85 billion by 2040, while the emotional assessment market is expected to reach $25 billion by 2030 and $60 billion by 2040 [8] Challenges and Recommendations - Key challenges for BCI technology include data collection and interpretation, biocompatibility of materials, energy consumption, and cost-effectiveness for large-scale deployment [9] - Continuous policy support is essential for BCI development, including the establishment of specialized review systems, key research projects, and timely pricing adjustments within the healthcare framework [9]